SCHEMBL8552554

SCHEMBL8552554

CC#CC(=O)Oc1ccc(Cc2nc(-c3ccccc3)c(-c3ccccc3S(N)(=O)=O)o2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 8/20 0.39
NR4A2 P43354 13/20 0.39
RXRB P28702 6/20 0.39
NR4A1 P22736 4/20 0.36
NR4A3 Q92570 4/20 0.36
RXRG P48443 3/20 0.36
SCN9A Q15858 1/20 0.35
FAAH O00519 1/20 0.35
F10 P00742 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ABCC4 O15439 1/20 0.35
C5 P01031 1/20 0.35
LMNA P02545 1/20 0.35
CHRM2 P08172 1/20 0.35
CYP3A4 P08684 1/20 0.35
CHRM1 P11229 1/20 0.35
DRD2 P14416 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
TBXA2R P21731 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9097717 0.82 RXRA (0.41) RXRANR4A2RXRBNR4A1NR4A3
SCHEMBL8556768 0.82 NR4A2 (0.45) RXRANR4A2RXRBNR4A1NR4A3
SCHEMBL9097865 0.81 NR4A2 (0.41) RXRANR4A2RXRBNR4A1NR4A3
SCHEMBL8553402 0.80 SCN9A (0.44) RXRANR4A2RXRBSCN9AF10
SCHEMBL9098566 0.80 RXRA (0.54) RXRANR4A2RXRBNR4A1NR4A3
SCHEMBL8552261 0.79 NR4A2 (0.45) RXRANR4A2RXRBNR4A1NR4A3
SCHEMBL8551313 0.79 NR4A2 (0.41) RXRANR4A2RXRBNR4A1NR4A3
SCHEMBL8560532 0.77 RXRA (0.46) RXRANR4A2RXRBNR4A1NR4A3
SCHEMBL8550595 0.77 NR4A2 (0.43) RXRANR4A2RXRBNR4A1NR4A3
SCHEMBL8560360 0.76 RXRA (0.44) RXRANR4A2RXRBNR4A1NR4A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0825989-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1998-03-04 EP claimed
WO-1996036617-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-11-21 WO claimed